Harmony Biosciences Holdings (HRMY) said late Tuesday that it launched an underwritten public offering of up to 8 million common shares by Marshman Fund Trust II and Valor IV Pharma Holdings.
The selling shareholders also plan to grant the underwriters a 30-day option to buy up to an additional 1.2 million shares of common stock.
The company said it is not offering any shares of common stock and will not receive any proceeds from the offering.
Price: 40.74, Change: -0.75, Percent Change: -1.81
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments